Original language | English (US) |
---|---|
Pages (from-to) | 1880-1882 |
Number of pages | 3 |
Journal | Lancet |
Volume | 367 |
Issue number | 9526 |
DOIs |
|
State | Published - Jun 10 2006 |
ASJC Scopus subject areas
- Medicine(all)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Lancet, Vol. 367, No. 9526, 10.06.2006, p. 1880-1882.
Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - Pneumococcal vaccination in developing countries
AU - Levine, Orin S.
AU - O'Brien, Katherine L.
AU - Knoll, Maria
AU - Adegbola, Richard A.
AU - Black, Steven
AU - Cherian, Thomas
AU - Dagan, Ron
AU - Goldblatt, David
AU - Grange, Adenike
AU - Greenwood, Brian
AU - Hennessy, Tom
AU - Klugman, Keith P.
AU - Madhi, Shabir A.
AU - Mulholland, Kim
AU - Nohynek, Hanna
AU - Santosham, Mathuram
AU - Saha, Samir K.
AU - Scott, J. Anthony
AU - Sow, Samba
AU - Whitney, Cynthia G.
AU - Cutts, Felicity
N1 - Funding Information: KLO'B has received research funding from Wyeth Vaccines, MSD, and sanofi pasteur, and participated in scientific advisory boards for Wyeth Vaccines and sanofi pasteur. SAM has received research funding and consultancy fees from Wyeth Vaccines and consultancy fees from sanofi pasteur. SB has received research grant support from Wyeth, MSD, sanofi pasteur, and GlaxoSmithKline. DG has received research funding support and consultancy fees from Wyeth, GlaxoSmithKline, and sanofi pasteur. RAA spent a sabbatical working in the laboratories of Wyeth Vaccines between 2001 and 2002. AG has received funding for travel and an unrestricted educational grant from Merck Vaccines. FC has served as a consultant for GlaxoSmithKline on rotavirus vaccine safety. RD has received grant and research support and has served as a scientific consultant for GlaxoSmithKline and Wyeth-Lederle Vaccines & Pediatrics in the past 3 years. HN has received research support from sanofi pasteur and consultation fees from GlaxoSmithKline. KPK has received research support and consultancy fees from Wyeth and GlaxoSmithKline. Other authors declare they have no conflict of interest.
PY - 2006/6/10
Y1 - 2006/6/10
UR - http://www.scopus.com/inward/record.url?scp=33744937045&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33744937045&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(06)68703-5
DO - 10.1016/S0140-6736(06)68703-5
M3 - Comment/debate
C2 - 16765742
AN - SCOPUS:33744937045
SN - 0140-6736
VL - 367
SP - 1880
EP - 1882
JO - The Lancet
JF - The Lancet
IS - 9526
ER -